BBS Pharmaceuticals News

[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]

July 18, 2020

Export Control Legislation Amendment (Certification of Narcotic Exports) Bill passes in Australia…

BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the Australian Parliament in passing the Export […]
June 18, 2020

Adrian Pederick MP applauds BBS on their site progress…

It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour to welcome local Member of Hammond, […]
June 11, 2020

Regional Development Australia Murraylands & Riverland impressed with BBS’s progress

It has been a busy and incredibly productive start of the week here at BBS as we are entering the second half of the year. This […]
May 28, 2020

Minister for Trade and Investment, David Ridgway visits BBS’s facility

It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and production facility. Together with BBS’s Corporate […]
April 30, 2020

Australian government unveils proposal for over-the-counter CBD

Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make it available over the counter in […]
April 23, 2020

BBS’s CEO John Dagas addresses Covid -19 and moving forward…

These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off, our hearts go out to anyone […]
April 14, 2020

Australia’s legal cannabis market predicted to bloom to $1.5 billion by 2025

As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to break through the barrier of US$1.5 […]
March 27, 2020

Industry Breakthough as Australian Senate Committee pushes for legalisation and increased patient access to medicinal cannabis in Australia!

The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers to patient access to medicinal cannabis in Australia’. In its 118-page long document, […]
March 12, 2020

TGA to expand quality audits for medicinal cannabis…

In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]